Regulatory and Economic Aspects in Oncology: 213 (Recent Results in Cancer Research, 213) - Image 1

£87.26

Springer Regulatory and Economic Aspects in Oncology: 213 (Recent Results in Cancer Research, 213)

Name: Regulatory and Economic Aspects in Oncology: 213 (Recent Results in Cancer Research, 213)
Brand: Springer
Price: 87.26 GBP
Availability: InStock

Oncology

It has never been this cheap. We have no record of a lower price.

£87 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 72 days · 72 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 72 days • 1 price levels

Days at Price

Price Analysis

Most common price: £87 (72 days, 100.0%)

Price range: £87 - £87

Price levels: 1 different prices over 72 days

Description

This book explores topics of importance to all who have an interest in economic methods for assessment of the efficacy and effectiveness of new cancer treatments and in regulatory measures relating to their marketing authorization and pricing. Targeted therapies and modern immunotherapy are placing a substantial strain on health care budgets. Regulation and economic methods to assess the parameters for establishing efficacy and effectiveness are therefore of prime importance. Payer authorities have to determine whether the use of these novel therapies yields clinical benefits that justify their increasing cost. In the simplest terms, cost-effectiveness analyses quantify the ratio between the extent to which an intervention raises healthcare costs and the extent to which it improves health outcomes. Rigorous cost-effectiveness analyses translate all health outcomes into quality-adjusted life years. On the other hand, in order to sustain innovation, price regulations must be coupled with efforts to ensure that drug companies are still able to recoup their investments in high-risk and high-costs research programs. Ultimately, decisions regarding health care expenditures are also a question of society’s willingness to pay.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3030012069
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 23 January 2019
Listed Since: 21 August 2018

Barcode

No barcode data available

Springer Regulatory and Economic Aspects in Oncology: 213 (Recent Results in Cancer Research, 213)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Assessing the Economic Value of Anticancer Therapies: 148 (Recent Results in Cancer Research, 148)

Side Effects of Medical Cancer Therapy: Prevention and Treatment

Ethical Challenges in Oncology: Patient Care, Research, Education, and Economics

Handbook of Targeted Cancer Therapy and Immunotherapy

Oxford Textbook of Cancer Biology - Oxford University Press

Springer Cancer Chemotherapy Volume 36 - Research Series

Critical Developments in Cancer Immunotherapy

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research)

Cancer Chemotherapy, Immunotherapy, and Biotherapy

Cancer Biology and Therapeutics

The Bethesda Handbook of Clinical Oncology

Cancer Chemotherapy 1: Cancer Treatment and Research: 7

Methods and Biostatistics in Oncology: Understanding Clinical Research as an Applied Tool

Targeted Cancer Therapy: A Ha: A Handbook for Nurses

Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias: 38 (Cancer Treatment and Research, 38)

The MASCC Textbook of Cancer Supportive Care and Survivorship